Sr. Vice President Clinical Operations and Clinical Outsourcing @ Bluejay Therapeutics (Acquired by Mirum Pharmaceuticals) (March 2025 - January 2026)
Senior Vice President, Clinical Operations and Outsourcing @ ALX Oncology (January 2024 - March 2025)
Vice President Clinical Operations and Clinical Outsourcing @ ALX Oncology (June 2022 - January 2024)
Executive Director @ ALX Oncology (July 2020 - June 2022)
Senior Director Clinical Operations @ (June 2018 - June 2020)
Director Clinical Operations @ (June 2016 - May 2018)
Senior Program Manager and Associate Director Clinical Operations @ (June 2012 - June 2016)
Senior Program Manager @ Metabolex (April 2007 - June 2012)
Sr. CRA @ Cell Genesys (January 2004 - January 2007)
CRA @ Mentor (January 2003 - January 2004)
Research Associate @ ICN Pharmaceuticals (April 2000 - January 2003)
Technical Specialist @ (July 1998 - December 1999)
Sue Naim Education
UCLA
Sue Naim Skills
Biotechnology
CRO
Clinical Development
Clinical Monitoring
Clinical Research
Clinical Trial Management
Clinical Trials
Diabetes
Drug Development
EDC
FDA
GCP
Immunology
Infectious Diseases
Lifesciences
Molecular Biology
Oncology
Pharmaceutical Industry
Regulatory Affairs
Regulatory Submissions
Sop
Therapeutic Areas
Research
Microsoft Excel
Healthcare
Hospitals
Strategic Planning
Microsoft Word
Sue Naim Summary
Sue Naim, based in California, United States, is currently a Senior Vice President, Clinical Operations at Mirum Pharmaceuticals, Inc.. Sue Naim brings experience from previous roles at Bluejay Therapeutics (Acquired by Mirum Pharmaceuticals) and ALX Oncology. Sue Naim holds a UCLA. With a robust skill set that includes Biotechnology, CRO, Clinical Development, Clinical Monitoring, Clinical Research and more. Sue Naim has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Sue Naim?
Find contact details for 700 million professionals.